Onconova Therapeutics (ONTX) Reports Q3 Loss of $0.29/Share
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Onconova Therapeutics (NASDAQ: ONTX) reported Q3 EPS of ($0.29), versus ($2.60) reported last year. Revenue for the quarter came in at $1.7 million, versus $1.6 million reported last year.
For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades Himax Technologies (HIMX) to Neutral
- Commerce Bancshares (CBSH) Tops Q4 EPS by 1c
- Biomerica, Inc. (BMRA) Reports Q2 EPS of $0.02
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!